期刊文献+

骨桥蛋白在葡萄胎、先兆子痫疾病中的表达 被引量:3

The expression of osteopontin in hydatidiform mole and preeclampsia
下载PDF
导出
摘要 目的通过检测骨桥蛋白(osteopontin,OPN)在葡萄胎及先兆子痫疾病中的表达情况来探讨OPN在两种疾病中可能参与的发病机制。方法采用免疫组化S-P法及逆转录多聚酶链反应(RT-PCR)检测方法,来比较葡萄胎组织与早孕绒毛、先兆子痫与正常足月胎盘组织中OPN的表达情况。结果各组组织中均有OPNmRNA(245kb)及其蛋白的表达,在相对表达量上,正常早孕绒毛组织中的表达高于葡萄胎组织(P<0.05);正常足月胎盘组织中的表达量也高于先兆子痫患者胎盘组织(P<0.05)。结论OPN在胎盘绒毛组织中的表达差异性,可能与葡萄胎、先兆子痫等滋养层密切相关的妊娠疾病的病理发生过程有一定的关系。 [Objective] To detect the osteopontin (OPN) in the hydatidiform mole or preeclampsia which is closely correlated with trophoblast to explore the role of OPN in pathogenesis of these disease. [Methods] Immunohistochemical staining (S-P method) and reverse transcription polymerase chain reaction (RT-PCR) were used to detect the expression of OPN in tissues of hydatidiform mole, 1st trimester villi, placenta with preeclampsia and normal term placenta. [Remits] OPN were expressed in all tissues. Additionally, the expression levels of OPN were higher in 1st trimester villi than those in hydatidfform mole (P 〈0.05), and the expression levels of OPN in normal term placenta were higher than those in placenta with preeclampsia (P 〈0.05). [Conclusions] The changes of OPN expressions in placenta tissues may be involved in the pathogenesis of trophoblast associated diseases of pregnancy such as hydatidiform mole and preeclampsia.
作者 薛菡 李红发
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第5期747-750,共4页 China Journal of Modern Medicine
关键词 胎盘 骨桥蛋白 葡萄胎 先兆子痫 placenta esteopontin hydafidiform mole preeclampsia
  • 引文网络
  • 相关文献

参考文献10

  • 1BRIESE J, OBERNDORFER M, PATSCHENIK C, et al. Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells[J]. J Clin Endoerinol Metab, 2005, 90: 5407-5413.
  • 2MEISSER A, CHARDONNENS D, CAMPANA A, et al. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases[J]. Mol Hum Reprod, 1999, 5(3): 252-260.
  • 3WAI PY, KUO PC. The role of osteopontin in tumor metastasis [J]. J Surg Res, 2004, 121(2): 228-241.
  • 4JOHNSON GA, BURGHARDT RC, BAZER FW, et al. Osteopontin: roles in implantation and placentafion [J]. Biol Reprod,2003, 69(5): 1458-1471.
  • 5PHILIP S, BULBULE A, KUNDU GC. Matrix metalloproteinase-2: Mechanism and regulation of NF-κ B-mediated activation and its role in cell motility and ECM-invasion[J]. Glycoconjugate J, 2004, 21: 429-441.
  • 6ISAKA K, USUDA S, ITO H, et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts[J]. Placenta, 2003, 24(1): 53-64.
  • 7BATORFI J, FULOP V, KIM JH, et al. Osteopotin is down-regulated in hydatidiform mole [J]. Gynecol Oncol, 2003, 89: 134-139.
  • 8林其德.妊娠高血压综合征病因学研究进展与展望[J].中华妇产科杂志,2003,38(8):471-473. 被引量:138
  • 9JOHNSON GA, BURGHARDT RC, JOYCE MM, et al. Osteopontin is synthesized by uterine glands and a 45-kD cleavage fragment is localized at the uterine-placental interface throughout ovine pregnancy[J]. Biol Reprod, 2003, 69(1): 92-98.
  • 10RAFFETTO JD, KHALIL RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease[J]. Biochem Pharmacol, 2008, 75(2): 345-359.

二级参考文献1

共引文献137

同被引文献32

  • 1张红云,张延丽,何玉洁,冯艳华.脂联素和TNF-α在子痫前期患者胎盘组织中的表达[J].基层医学论坛,2009,13(16):483-485. 被引量:4
  • 2乔宠,程大丽,张淑兰,王春晖,林其德.KiSS-1基因和基质金属蛋白酶-9在滋养细胞浸润调控中的作用[J].中华医学杂志,2005,85(12):839-842. 被引量:16
  • 3Kliman H J. Uteroplacental blood flow: the story of decidualization, menstuation and trophoblast invasion[J]. Am J Pathol,2000,157(6) : 1759-1768.
  • 4Whitley G S, Dash P R, Ayling L-J, et al. Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia[J]. Am J Pathol,2007, 170(6) : 1903-1909.
  • 5Cohen M, Bischof P. Factors regulating trophoblasl invasion[J]. Gynecol Obstet Invest,2007,64(3) : 126-130.
  • 6Bischof P, Meisser A. Campana A. Paracrine and autocrine regulators of trophoblast invasion-a review[J]. Placenta, 2000, 21(Suppl A) :S55-S60.
  • 7Velinov N, Aebersold D, Haeni N, et al. Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma[J]. Int J Biol Markers,2007,22(4):265-273.
  • 8Stracke J O, Hutton M, Stewart M, et al. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent Dasement membrane degrading enzyme[J]. J Biol Chore, 2000,275 (20) : 14809-14816.
  • 9Afonso S, Romagnano L, Babiarz B. Expression of cathepsin proteinases by mouse trophoblast in vivo and in vitro[J]. Dev Dyn,1999,216(4-5):374-384.
  • 10Merchant SH,Amin MB,Viswanatha DS,et al.p57kip2 immunohistochemistry in early molar pregnancies:emphasis on its complementary role in the differential diagnosis of hydropic abortuses[J].Hnm Pathol,2005,36(2):180-186.

引证文献3

二级引证文献14

;
使用帮助 返回顶部